Impressive Results With Lenvatinib in Challenging Tumors Multitargeted TKI achieves strong ORR in advanced gastroenteropancreatic NETs May 10, 2021
No Clarity for Role of Laser Therapy in Vulvar Lichen Sclerosus Mixed results from two small randomized clinical trials May 10, 2021
Doubling Down on Immunotherapy in Advanced Melanoma Checkpoint inhibitor combo active after upfront anti-PD-1/L1 therapy May 09, 2021
Thiotepa-Based Conditioning Promising for Primary CNS Lymphoma Commonly used regimens with autologous transplant improved survival May 06, 2021
Is Dynamic AFP-R Key to Transplant Selection in Liver Cancer? Dynamic alpha-fetoprotein response improved prediction of patient outcomes May 05, 2021
Report: Worst Hospitals for Unnecessary Procedures Lown Institute says report is the first to name hospitals with high rates of overuse May 04, 2021
Op-Ed: Is FDA's Cigarette Ban Just Smoke and Menthols? Actually implementing a ban on menthol cigarettes and cigars could take years May 03, 2021
SBRT Safe for Cancer Patients With Multiple Metastases Late adverse events in phase I trial indicate need for extended follow-up May 03, 2021
What's Behind the Mysterious Chest Pain in Bladder Cancer Patient? Cardiomyopathy risks interrupting cancer treatment, worsening prognosis May 03, 2021
'It's a Straw-Man Argument': What We Heard This Week Quotable quotes from ΒιΆΉ΄«Γ½'s sources May 02, 2021
New Clues to Sleep Problems, Solutions in Cancer Patients Studies in GI and breast cancers zero in on sleep disturbance during active treatment Apr 30, 2021
FDA Panel Splits on Anti-PD-1 Monotherapy in HCC All thumbs up for pembrolizumab, pending further data, but no such luck for nivolumab Apr 30, 2021
Treatment Type a Non-Factor in Prostate Cancer Patients' Anxiety Researchers emphasized importance of psychological interventions as problems arise Apr 29, 2021
Lung Cancer Survival Continues to Rise With Immunotherapy Twice as many patients with advanced NSCLC alive at 5 years with pembrolizumab vs chemo Apr 29, 2021
Vadadustat Matches Standard for CKD-Related Anemia, With Caveat Jury still out on drug's heart safety, which differed depending on dialysis dependence Apr 28, 2021
Healthy Lifestyle May Mitigate Heart Risks for Young Cancer Survivors Literature reviews find particularly persistent cardiovascular complications in these patients Apr 28, 2021
What to Do With a Rare, Aggressive Bladder Cancer Case authors lament scant information on treatments or outcomes Apr 26, 2021
Why Clotting Happens When Platelets Are Low A hematologist explains the counterintuitive concept of clots with low platelets Apr 23, 2021
Chemotherapy Nausea Linked to Stress, Neuropsych Symptoms High frequency of CIN leads to stress and more severe neuropsychological symptoms Apr 23, 2021
Auricular Acupressure May Relieve Neuropathy in Breast Cancer First randomized trial of the noninvasive technique in such patients Apr 22, 2021
PD-1 Inhibitor Approved for dMMR Endometrial Cancer Dostarlimab led to 42.3% response rate in recurrent/advanced disease Apr 22, 2021
Late ADT a Problem in Prostate Cancer Late dosing of LHRH agonists happens too frequently, researchers report Apr 22, 2021
Surveillance Spurned for Small Papillary Thyroid Tumors Nearly all head and neck surgeons would opt for lobectomy or total thyroidectomy Apr 22, 2021
No More Men Need to Die From Transrectal Prostate Biopsies A movement toward transperineal biopsies Apr 21, 2021
Are Post-Mastectomy Lymphedema Precautions Needed for All? Standard risk reduction efforts may not decrease incidence, researchers say Apr 21, 2021
Olympic Gold Medalist Nathan Adrian's Testicular Cancer The swimmer's diagnosis, treatment, and an "extra year" of pandemic prep for Toyko Apr 20, 2021
Poloxamer 188 Flops for Sickle Cell Disease Pain Study found no difference in duration of vaso-occlusive episodes versus placebo Apr 20, 2021
New Anti-PD1 Drugs Boost Survival in Treated Lung Cancer Questions about generalizability of results with China-developed therapies Apr 14, 2021
Another Player in Advanced Bladder Cancer Accelerated FDA approval of sacituzumab govitecan after chemo, immunotherapy Apr 14, 2021
Targeted Drug Yields Durable Responses in Rare Blood Neoplasm Most advanced systemic mastocytosis patients responded to KIT D816V inhibitor Apr 13, 2021
Another FGFR Inhibitor Active in Bile Duct Cancers Clinical benefit rate of 82% in patients selected for FGFR2 fusions, rearrangements Apr 13, 2021
Dual Targeted Tx a 'Meaningful' Option in BRAF-Mutant Glioma One-third of glioblastoma patients responded to dabrafenib-trametinib Apr 12, 2021
More Benefit With Taxane for Aggressive Metastatic Prostate Cancer Higher clinical benefit rate with front-line cabazitaxel versus androgen receptor inhibitor Apr 12, 2021
Triple-Negative Breast Cancers Not All the Same Histology tied to treatment response, outcomes Apr 12, 2021
A Win for Nivolumab as Preoperative Therapy for Lung Cancer Pathologic CR rate 12 times higher with the addition of anti-PD-1 agent to chemo Apr 11, 2021
Immunovirotherapy Shows Promise in Pediatric High-Grade Glioma Small study showed responses in 11 of 12 patients Apr 11, 2021
Nivolumab Alone Prevails in Resected Melanoma Adding ipilimumab in adjuvant setting failed to improve relapse-free survival Apr 11, 2021
Mixed Results for Immunotherapy in Metastatic Prostate Cancer Combination trial missed response endpoint but exceeded historical results Apr 11, 2021
